Interface Biologics (aka IBI)

Nanotechnology surface treatments for combination medical devices that address nosocomial (in-hospital) infections and thrombus

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Interface Biologics (aka IBI) plus 5337 other startups.